Achievements of the Center
Welcome to the Daegu-Gyeongbuk Medical Cluster, the future of the global medical industry!
Achievements of the New Drug Development Center
-
Demand-oriented R&D
- New drug pipeline discovery
(12 cases) - Key research for 86 institutions
(279 cases)
(as of April 2017, cumulative total)
- New drug pipeline discovery
-
Infrastructure establishment and promotion
- Base technology standardization
(4 cases) - Technological analysis services
(272 cases)
(as of April 2017, cumulative total) - Provision of research space for start-ups
- Base technology standardization
-
Establishment of a research-facilitating environment
- Policy planning and implementation
- Demand surveys and public hearings
- Organization of a consultative body for related institutions
- DGMIF Forum (102 sessions)
(as of April 2017, cumulative total)
-
Technological transfers (2 cases)
- Candidate compounds to overcome chemo resistance in leukemia (Dec 2016)
- Candidate compounds to treat anaplastic thyroid cancer (ATC) (April 2016)
-
Improvement of research quality
- Support for the discovery of lead compounds and candidate compounds
- Support for improved efficacy, reduced toxicity and optimization
-
Establishment of a nurturing environment for new drug development
- Compliance with FDA requirements, accumulation of pharmacokinetics and metabolic analysis technologies
- Localization of foreign services and reduction of unit prices
- Reduction of the time needed to discover hit and lead compounds
- Promotion of first-in-class compound discoveries
01.
New Drug Development Center
